Antigenicity of Different Antigranulocytes Antibodies Assessed By Hama Follow-Up In Patients Undergoing Immunoscintigraphic Detection of Infections

  • K. Seybold
  • M. Trinkler
  • L. D. Frey
  • J.Th. Locher
Part of the NATO ASI Series book series (NSSA, volume 262)

Abstract

In the last years increasing numbers of patients have being given murine monoclonal antibodies (Mabs) for radioimmunodetection (RID) and for immunotherapy. Especially, since the introduction of the immunoscintigraphy of infections (Locher 1986) antigranulocytes antibodies (AGAb) are administered in a rapidly growing scale for RID of infections and bone metastasis. Due to this, the problem of the potential human immunoreaction against murine Mabs, i.e. production of HAMA (human antimouse antibodies) has become more relevant (Courtenay-Luck 1986, Schroff 1985), because HAMA may influence the diagnostic outcome of immunoscintigraphy (Hertel 1990, Pimm 1985, van Kroonenburgh 1988). Despite that, in the recent literature there are only poor reports on HAMA follow-up in patients undergoing immunoscintigraphy of infections (Lind 1990). So we evaluated the clinical relevance of HAMA, and its determination in a larger number of patients by using various and differently labeled antigranulocytes antibodies.

Keywords

Adenocarcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Courtenay-Luck NS et al (1986). Developement of primary and secondary immunresponses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplassms. Cancer Res, 46: 6489–6493.PubMedGoogle Scholar
  2. Fritsche H (1990). Immunoscintographic follow-up studies with the 99m-Tc-marked monoclonal anti-CEA antibody BW 431/26. Act Med Austriac, 17: 44–46.Google Scholar
  3. Hertel A, Baum R P, Auerbach B, Herrmann A, Hoer G, (1990). The clinical relevance of human anti-mouse anti-body (HAMA) in immunoscintigraphy. Nuklearmedizin, 29: 221–227.PubMedGoogle Scholar
  4. Joseph K, Höffken H, Damann V (1987). In-vivo Markierung von Granulozyten mit 99mTc markierten monoklonalen Antikörpern: Erste klinische Ergebnisse. Nuccompact, 18: 223–226Google Scholar
  5. LaFontaine GS, Hansen HJ, Weiss BF, Goldenberg DM (1988). Enzyme immunoassay for the detection of circulating immunoglobulines in humans to mouse monoclonal antibody (HAMA). Presented at the Third International Conference of Monoclonal Antibody Immunoconjugates for Cancer: February 4–6.Google Scholar
  6. Leitha T, Walter R, Schlick W, Dudczak R (1991). 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma. Chest, 99: 14–19.PubMedCrossRefGoogle Scholar
  7. Lind P, Langsteger W, Koltringer P, Dimai HP, Passl R, Eber O (1990). Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med, 31: 417–423.PubMedGoogle Scholar
  8. Locher JT, Seybold K, Andres RY, Schubiger PA, Mach JP, Buchegger F (1986). Imaging of inflammatory lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies. Nucl Med Commun, 7: 695–670.Google Scholar
  9. Pimm MW et al (1985). The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med, 26: 1011–1023.PubMedGoogle Scholar
  10. Schroff RW et al (1985). Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res, 45: 879–885.PubMedGoogle Scholar
  11. Seybold K, Locher JT, Coosemans C, Andres RY, Schubiger PA, Bläuenstein P (1988). Immunoscintigraphic localization of inflammatory lesions: Clinical experiences. Eur J Nucl Med, 13: 587–593.PubMedCrossRefGoogle Scholar
  12. Van Kroonenburgh M J, Pauwels EK (1988). Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseases. Nucl Med Commun, 9: 919–930.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • K. Seybold
    • 1
  • M. Trinkler
    • 1
  • L. D. Frey
    • 1
  • J.Th. Locher
    • 1
  1. 1.Department of Nuclear Medicine Kantonsspital AarauAarauSwitzerland

Personalised recommendations